Jeffrey L. Ives, Director at Cara Therapeutics, Inc. (CARA), sold 2,500 shares at $16.13 ($40K) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2021-11-16 | $262K | — | Filing → |
| CARA | SELL | 2021-06-07 | $33K | — | Filing → |
| CARA | SELL | 2020-11-24 | $39K | — | Filing → |